v3.22.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash Flows From Operating Activities    
Net loss $ (2,247) $ (4,207)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 781 1,532
Interest accretion expense 121 135
Bad debt (recovery) expense (140)
Mark to market on warrants (63) 41
Amortization of deferred financing fees 10
Amortization of loan costs 52
Interest - note payable 92
Stock-based compensation 302 259
ESPP expense 23 27
Change in fair value of note payable (107)
Change in fair value of contingent consideration (57)
Other gains and expenses, net (3)
Changes in operating assets and liabilities:    
(Increase) decrease in accounts receivable (1,083) 317
Increase in other current assets (83) (253)
Increase in other long-term assets (1)
Increase (decrease) in accounts payable 1,235 (1,534)
Increase (decrease) in accrued salaries and bonus 377 (988)
Decrease in accrued liabilities (556) (293)
Increase in long-term liabilities 37 14
Net cash used in operating activities (1,254) (5,006)
Cash Flows From Investing Activity    
Purchase of property and equipment (19)
Sale of property and equipment 39
Net cash (used in) provided by investing activities (19) 39
Cash Flows From Financing Activities    
Issuance of common stock, net of expenses 59 108
Loan proceeds - related parties 5,000
Financing fees - related party (74)
Borrowings on line of credit 1,000
Net cash provided by financing activities 1,059 5,034
Net (decrease) increase in cash, cash equivalents and restricted cash (214) 67
Cash, cash equivalents and restricted cash – beginning 3,314 3,372
Cash, cash equivalents and restricted cash – ending $ 3,100 $ 3,439

Source